LESSONS FOR COVID 19 ERA: IMPACT OF DELAYS IN SURGERY ON BIOCHEMICAL RECURRENCE-FREE SURVIVAL AND ADVERSE ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS